Clinical Trial Update: Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Regeneron is conducting a Phase 1/2 clinical trial evaluating linvoseltamab in adults with relapsed or refractory multiple myeloma, and the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Linvoseltamab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING